
The Anti-CD30 Monoclonal Antibody SGN-30 Promotes Growth …
2002年7月1日 · In this report, we describe the antiproliferative activities of the mouse antihuman CD30 mAb AC10 (20) on HD cells and the antitumor activity of SGN-30, a chimeric antibody derived from AC10.
Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN ...
The unconjugated cAC10 antibody SGN-30 (Wahl et al, 2002) and SGN-35 are both under evaluation in clinical trials for the treatment of CD30-positive haematological malignancies, including ALCL and HL (Schnell & Borchmann, 2006).
Alan F. Wahl's research
SGN-30, a chimeric monoclonal antibody with apoptotic-signaling activity against CD30-positive malignancies, is currently in Phase II clinical evaluation against anaplastic large cell lymphoma...
Alan WAHL | The California Institute for Biomedical
SGN-30, a monoclonal antibody with activity against CD30+ malignancies, is currently in phase II clinical evaluation for treatment of Hodgkin's disease (HD) and anaplastic large cell lymphoma.
[PDF] The anti-CD30 monoclonal antibody SGN-30 ... - Semantic …
2002年7月1日 · SGN-30 is being developed for the treatment of patients who have HD that is refractory to initial treatment or who have relapsed and have limited therapeutic options and is able to inhibit the growth of HD cell lines in vitro.
Ph'nglui mglw'nafh Cthulhu R'lyeh wgah'nagl fhtagn. #8 - GitHub
2015年4月10日 · Sgn'wahl namnahn' stell'bsna ch' vulgtm ph'sgn'wahl hupadgh zhro, nnnshogg ep nog nw throd ron ehye, ee gnaiih y-shtunggli ftaghu Tsathoggua syha'h nnnehye, 'ai h'fm'latgh y-syha'h 'bthnk ngkadishtu ngshogg.
Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's
SGN-30, a monoclonal antibody with activity against CD30+ malignancies, is currently in phase II clinical evaluation for treatment of Hodgkin's disease (HD) and anaplastic large cell lymphoma. The mechanisms underlying SGN-30's antitumor activity were investigated using cDNA array of …
The anti-CD30 monoclonal antibody SGN-30 promotes growth ... - PubMed
2002年7月1日 · SGN-30 is being developed for the treatment of patients who have HD that is refractory to initial treatment or who have relapsed and have limited therapeutic options. The leukocyte activation marker CD30 is highly expressed …
[PDF] The Anti-CD 30 Monoclonal Antibody SGN-30 ... - Semantic …
SGN-30 is being developed for the treatment of patients who have HD that is refractory to initial treatment or who have relapsed and have limited therapeutic options. The leukocyte activation marker CD30 is highly expressed on the Reed Sternberg cells of Hodgkin’s disease (HD).
Vtg Impresionen Oil Painting Oil On Board Egyptian Priestesses
Find many great new & used options and get the best deals for Vtg Impresionen Oil Painting Oil On Board Egyptian Priestesses 29"x30" Sgn WAHL at the best online prices at eBay! Free shipping for many products!